After taking over automobiles.......Next target for Japanese companies .......Global Mergers in Pharma

Last year some reports stated that Japanese companies were the most aggressive player in global merger and acquisitions. In these many years we have seen that Japanese pharma companies have gone for global acquisition which include Takede acquiring Millenium, Eisai taking over MGI pharma, Hisamitsu Pharmaceuticals went into acquire Noven pharmaceutical, Diachii Sankyo acquiring one of the world's largest generic drug maker Ranbaxy in India. Some time back in mid July this year the news was that one more Japanese firm was there to bid for Solvey in Europe and Today at 6:30 AM EST- Sep 3, 2009 news stand main headline all over the world was that Dannipon Sumitomo which some time back started its North American operation has decided to buy out Sepracor for $2.6 billion. With this deal Danippon will be able expand its portfolio in global CNS segment. But the truth is United States is still considerd highest source of revenue for both European and Asian companies.